Potassium channel activator useful in partial-onset seizures


Retigabine (ezogabine in the U.S.), which activates KCNQ2/2 potassium channels, is effective as an adjunctive treatment in partial-onset seizures, according to the results of the phase III RESTORE 1 trial (French et al. Neurology 2011; 76: 1555-1563).

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page